Seguir
Michael MacManus
Michael MacManus
Professor University of Melbourne, Radiation Oncologist, Peter MacCallum Cancer Centre
Email confirmado em petermac.org
Título
Citado por
Citado por
Ano
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell …
MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, ...
Journal of Clinical Oncology 21 (7), 1285-1292, 2003
5262003
Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
MP Mac Manus, RT Hoppe
Journal of Clinical Oncology 14 (4), 1282-1290, 1996
5221996
Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007
M MacManus, U Nestle, KE Rosenzweig, I Carrio, C Messa, O Belohlavek, ...
Radiotherapy and oncology 91 (1), 85-94, 2009
4692009
Abscopal effects of radiation therapy: a clinical review for the radiobiologist
S Siva, MP MacManus, RF Martin, OA Martin
Cancer letters 356 (1), 82-90, 2015
4542015
High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy
MP Mac Manus, RJ Hicks, JP Matthews, A Hogg, AF McKenzie, A Wirth, ...
International Journal of Radiation Oncology* Biology* Physics 50 (2), 287-293, 2001
3702001
18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer
RJ Hicks, V Kalff, MP MacManus, RE Ware, A Hogg, AF McKenzie, ...
Journal of Nuclear Medicine 42 (11), 1596-1604, 2001
3032001
Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non–small-cell lung cancer: a prospective study
V Kalff, RJ Hicks, M P MacManus, DS Binns, AF McKenzie, RE Ware, ...
Journal of clinical oncology 19 (1), 111, 2001
2972001
F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high …
MP Mac Manus, RJ Hicks, DL Ball, V Kalff, JP Matthews, E Salminen, ...
Cancer 92 (4), 886-895, 2001
2782001
The utility of 18F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification
RJ Hicks, V Kalff, MP MacManus, RE Ware, AF McKenzie, JP Matthews, ...
Journal of Nuclear Medicine 42 (11), 1605-1613, 2001
2432001
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review
S Siva, M MacManus, D Ball
Journal of Thoracic Oncology 5 (7), 1091-1099, 2010
2402010
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
A Wirth, JF Seymour, RJ Hicks, R Ware, R Fisher, M Prince, ...
The American journal of medicine 112 (4), 262-268, 2002
2352002
A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
T Leong, C Everitt, K Yuen, S Condron, A Hui, SYK Ngan, A Pitman, ...
Radiotherapy and oncology 78 (3), 254-261, 2006
2282006
Should extrapulmonary small cell cancer be managed like small cell lung cancer?
SM Brennan, DL Gregory, A Stillie, A Herschtal, M Mac Manus, DL Ball
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
2272010
Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211
M Hatt, JA Lee, CR Schmidtlein, IE Naqa, C Caldwell, E De Bernardi, ...
Medical physics 44 (6), e1-e42, 2017
2062017
Early FDG-PET imaging after radical radiotherapy for non–small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound …
RJ Hicks, MP Mac Manus, JP Matthews, A Hogg, D Binns, D Rischin, ...
International Journal of Radiation Oncology* Biology* Physics 60 (2), 412-418, 2004
2062004
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure
MPM Manus, RJ Hicks, JP Matthews, A Wirth, D Rischin, DL Ball
Lung cancer 49 (1), 95-108, 2005
1942005
Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?
OA Martin, RL Anderson, K Narayan, MP MacManus
Nature reviews Clinical oncology 14 (1), 32-44, 2017
1762017
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy
M Fay, A Tan, R Fisher, M Mac Manus, A Wirth, D Ball
International Journal of Radiation Oncology* Biology* Physics 61 (5), 1355-1363, 2005
1662005
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014
T Konert, W Vogel, MP MacManus, U Nestle, J Belderbos, V Grégoire, ...
Radiotherapy and Oncology 116 (1), 27-34, 2015
1562015
Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma
A Wirth, M Foo, JF Seymour, MP MacManus, RJ Hicks
International Journal of Radiation Oncology* Biology* Physics 71 (1), 213-219, 2008
1522008
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20